Agrochemicals firm Valiant Organics declares Q4FY22 result: INR 3,476 Mn Operational Revenue 16.40% Operating EBITDA Margin 10.67% PAT Margin INR 570 Mn Operating EBITDA INR 371 Mn Profit After Tax INR 11.12/ Share EPS Strong Revenue growth in Q4FY22 & Full Year FY22 on a YoY and QoQ basis owing to higher prices as well as volume addition on account of PAP ramp up Raw Material prices and market volatility continued to remain under pressure due to the geopolitical situations PAP ramp up continues to be on track and we have now achieved production of 300+ MT per month OAP & Pharma Intermediates projects both are on-track with no significant delays. OAP Phase 1 trial run has been successful and both OAP and Pharma Intermediates plant expected to commence production from Q2-FY23 Direct and deemed exports together accounted for 14% in Q4-FY22 and 16% in FY22 Result PDF